Faisal N. Cheema

Geriatrics | Oncology | Hematology
710 Lawrence Expy
4th Floor Dept 440
Santa Clara, CA 95051

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications

Community Experience With Pediatric-Inspired Regimens for Acute Lymphoblastic Leukemia in Adolescent and Young Adults.

Community Experience With Pediatric-Inspired Regimens for Acute Lymphoblastic Leukemia in Adolescent and Young Adults.

Journal: Cancer medicine
Published: June 13, 2025

A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612.

A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612.

Journal: Leukemia & lymphoma
Published: December 15, 2022

Double hit lymphoma - a case of unusual response after sequential aggressive chemotherapy and review of the literature.

Double hit lymphoma - a case of unusual response after sequential aggressive chemotherapy and review of the literature.

Journal: Clinical medicine insights. Case reports
Published: December 16, 2012
Showing 1-3 of 3

Last Updated: 09/26/2026